Michele Cerami February 8, 2019 When I was a young child I always knew that I wanted to secure a position in the healthcare field. I thought about becoming a Social Worker, Psychologist,...
read more
Non-hodgkin’s Lymphoma Cancer
Rituximab Enhanced Therapy Shows Promise against Non-Hodgkin’s Lymphoma
The New England Journal of Medicine published an article highlighting the synergizing effect of the Hu5F9-G4 (5F9) antibody when combined with Rituximab in eliminating B-cell non-Hodgkin’s...
read more
Gift of ‘Life’ for the One Who Had Accepted Death
Denise Kennan was diagnosed with non-Hodgkin’s Lymphoma when she was 8. It is a blood cancer that originates in your lymphatic system and spreads. Struggling to live the blessing of...
read more
Combo of Checkpoint Inhibitor and Rituximab Shows Effectiveness against Lymphoma
Almost one-third of patients with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma who had failed prior treatment saw their tumors completely eliminated by the combination of...
read more
Role of CAR-T Immunotherapy In Saving Blood Cancer Patients
Cellular immunotherapy is a process in which patient’s disease-fighting T-cells are extracted and engineered to identify the type of cancer. A special type of virus is used to insert DNA...
read more
DLBCL Can Be Treated Now and Victims Can Survive Longer
US Food of Drug and Administration approved Axi-cel for treatment of DLBCL last year. European Commission approved it this year. Axi-cel is an anti-CD19 chimeric antigen receptor (CAR T)....
read more
